HomeScience Asia Reviewvol. 8 no. 1 (2023)

Anti-parasitic Drug Ivermectin in the treatment of COVID-19: A Review

Fatimae I. Mariano | Elizabeth Y Tan | Maria Donabelle U Dean

 

Abstract:

The World Health Organization declared COVID-19 a pandemic in March 2020. As nations began to issue measures to combat the spread of the virus, it also saw dreadful consequences impacting the different sectors of the community. The search for cure was underway but since drug development can take years, repurposing of existing potential drugs became a trend. Ivermectin, an antiparasitic drug, piqued the curiosity of researchers since the preclinical study done by Caly, et al in 2020 showed promising results on its effect against SARS-CoV 2 virus. This article looks into a collection of published studies whether or not Ivermectin, given as treatment for COVID-19, improves patient outcomes.